Evidence map›Paper›PMID 33441644›Full record

ArticleScientific reports2021

On the information hidden in a classifier distribution.

Farrokh Habibzadeh, Parham Habibzadeh, Mahboobeh Yadollahie, Hooman Roozbehi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Data Distribution: Normal or Abnormal?Journal of Korean medical science · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Molecular diagnostic assays for COVID-19: an overview.Critical reviews in clinical laboratory sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Farrokh HabibzadehR&D Headquarters, Petroleum Industry Health Organization Polyclinic, Eram Blvd, 7143837877, Shiraz, Iran. Farrokh.Habibzadeh@gmail.com.
Parham HabibzadehPersian BayanGene Research and Training Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mahboobeh YadollahieR&D Headquarters, Petroleum Industry Health Organization Polyclinic, Eram Blvd, 7143837877, Shiraz, Iran.
Hooman RoozbehiPeyvand Clinical Laboratory, Shiraz, Iran.
National Iranian Oil Company (Iran) · IRShiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Classification tasks are a common challenge to every field of science. To correctly interpret the results provided by a classifier, we need to know the performance indices of the classifier including its sensitivity, specificity, the most appropriate cut-off value (for continuous classifiers), etc. Typically, several studies should be conducted to find all these indices. Herein, we show that they already exist, hidden in the distribution of the variable used to classify, and can readily be harvested. An educated guess about the distribution of the variable used to classify in each class would help us to decompose the frequency distribution of the variable in population into its components-the probability density function of the variable in each class. Based on the harvested parameters, we can then calculate the performance indices of the classifier. As a case study, we applied the technique to the relative frequency distribution of prostate-specific antigen, a biomarker commonly used in medicine for the diagnosis of prostate cancer. We used nonlinear curve fitting to decompose the variable relative frequency distribution into the probability density functions of the non-diseased and diseased people. The functions were then used to determine the performance indices of the classifier. Sensitivity, specificity, the most appropriate cut-off value, and likelihood ratios were calculated. The reference range of the biomarker and the prevalence of prostate cancer for various age groups were also calculated. The indices obtained were in good agreement with the values reported in previous studies. All these were done without being aware of the real health status of the individuals studied. The method is even applicable for conditions with no definite definitions (e.g., hypertension). We believe the method has a wide range of applications in many scientific fields.

Identifiers

PMID33441644
PMCPMC7807039
OpenAlexW3121033296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.